Physician

Michael Leonce Pezold, M.D.

According to 2025 Medicare claims, Michael Pezold, M.D. (NPI: 1720377856) practices vascular surgery in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is PROVIDENCE MEDICAL FOUNDATION (NPI: 1740584473; TIN: 330185031) and primary practice location at 95405-4559. Pezold is affiliated with the Health Connect Partners, LLC (ACO ID: A2342), participating under the MSSP model.

Pezold's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,017 traditional Medicare patients, billed 3,155 HCPCS/CPT codes, and received $506,773 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 315 prescription claims across 157 beneficiaries totaling $31,551 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 24 claims. Open Payments data shows 24 records totaling $2,507. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $28,831 to $506,773. Similarly, Part D prescription costs have moved sharply higher in recent years, from $570 to $31,551. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	49	184	$28,831
2021	249	973	$139,193
2022	556	1,728	$253,704
2023	820	2,393	$346,308
2024	1,017	3,155	$506,773

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	14	$570
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	26	46	$4,557
2022	80	136	$13,152
2023	112	259	$33,892
2024	157	315	$31,551

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	24	24	$15,357
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	369	469	$48,863
93880	Ultrasound of both sides of head and neck blood flow	187	209	$35,629
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	243	243	$32,032
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	238	265	$19,048
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	98	109	$14,946

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	22	1,193	$23,425
Clopidogrel	Clopidogrel Bisulfate	102	8,160	$1,412
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	192	$360
Gabapentin	Gabapentin	21	810	$299
Cilostazol	Cilostazol	13	886	$190

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$2,507	Penumbra, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Leonce Pezold, M.D.?

Tedicare shows public-source Medicare data for Michael Leonce Pezold, M.D. (NPI 1720377856), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Leonce Pezold, M.D. have ACO affiliation data?

Michael Leonce Pezold, M.D. is shown with ACO affiliation data for Health Connect Partners, LLC (MSSP, ACO ID A2342).

What billing organization is linked to Michael Leonce Pezold, M.D.?

Michael Leonce Pezold, M.D. is linked to PROVIDENCE MEDICAL FOUNDATION (billing NPI 1740584473) in the available physician profile data.

Does Michael Leonce Pezold, M.D. have Open Payments data?

Michael Leonce Pezold, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.